Growth plate closure and therapeutic interventions

Area of Science:

• Endocrinology
• Skeletal Biology
• Cell Biology

Background:

• Longitudinal bone growth determines human height, primarily driven by chondrocyte activity in the growth plates.
• The growth plate comprises distinct zones (resting, proliferative, hypertrophic) with specific chondrocyte functions essential for bone elongation.
• Growth plate senescence, marked by chondrocyte depletion and decreased proliferation, ultimately limits final adult height.

Purpose of the Study:

• To summarize the key factors controlling longitudinal bone growth and growth plate closure.
• To review current therapeutic interventions aimed at delaying growth plate senescence.
• To highlight the need for further research into the complex mechanisms regulating growth plate closure.

Main Methods:

• Review of existing literature on chondrocyte biology and growth plate development.
• Analysis of cellular, genetic, paracrine, and endocrine signaling pathways involved in growth plate closure.
• Examination of therapeutic strategies targeting growth plate senescence.

Main Results:

• Longitudinal bone growth depends on progenitor cell differentiation, chondrocyte proliferation, and timely calcification.
• Growth plate senescence involves depletion of progenitor cells and reduced chondrocyte activity, leading to growth cessation.
• Several therapeutic agents, including GnRH analogs and FGFR3 inhibitors, have been explored to modulate growth plate closure.

Conclusions:

• Elucidating the intricate mechanisms of growth plate closure is essential for advancing treatments for short stature, precocious puberty, and skeletal dysplasias.
• Further research into the signaling networks governing growth plate senescence can unlock novel therapeutic targets.
• A deeper understanding of growth plate biology is critical for addressing pediatric endocrine and skeletal disorders.